PatientsVille.com Logo

Cytarabine. Side Effects

PatientsVille

Common Cytarabine. Side Effects


The most commonly reported Cytarabine. side effects (click to view or check a box to report):

Haematocrit Decreased (1)
Febrile Neutropenia (1)
Febrile Bone Marrow Aplasia (1)
Red Blood Cell Count Increased (1)
Haemoglobin Decreased (1)
Hepatic Candidiasis (1)
Liver Abscess (1)
International Normalised Ratio Increased (1)
Hepatic Lesion (1)
Disseminated Intravascular Coagulation (1)


If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Cytarabine. Side Effects Reported to FDA


Cytarabine. Side Effect Report#5281884-4
Disseminated Intravascular Coagulation, Febrile Bone Marrow Aplasia, Haematocrit Decreased, Haemoglobin Decreased, Hepatic Candidiasis, Hepatic Lesion, International Normalised Ratio Increased, Liver Abscess, Red Blood Cell Count Increased
This is a report of a 77-year-old male patient (weight: NA) from Canada, suffering from the following health symptoms/conditions: acute myeloid leukaemia, who was treated with Cytarabine. Mfr: Mayne Pharma (dosage: 20 Mg/m2 Qd Sc, start time:
Nov 21, 2006), combined with: NA. and developed a serious reaction and side effect(s): Disseminated Intravascular Coagulation, Febrile Bone Marrow Aplasia, Haematocrit Decreased, Haemoglobin Decreased, Hepatic Candidiasis, Hepatic Lesion, International Normalised Ratio Increased, Liver Abscess, Red Blood Cell Count Increased after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Cytarabine. Mfr: Mayne Pharma treatment in male patients, resulting in Disseminated Intravascular Coagulation side effect. The patient was hospitalized.
Cytarabine. Side Effect Report#5281869-8
Febrile Neutropenia
This report suggests a potential Cytarabine. Mfr: Mayne Pharma Febrile Neutropenia side effect(s) that can have serious consequences. A 84-year-old male patient (weight: NA) from Canada was diagnosed with the following symptoms/conditions: acute myeloid leukaemia and used Cytarabine. Mfr: Mayne Pharma (dosage: 20 Mg/m2 Qd Sc) starting
Feb 21, 2007. After starting Cytarabine. Mfr: Mayne Pharma the patient began experiencing various side effects, including: Febrile NeutropeniaAdditional drugs used concurrently: NA.The patient was hospitalized. Although Cytarabine. Mfr: Mayne Pharma demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Febrile Neutropenia, may still occur.



The appearance of Cytarabine. on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

What are common Cytarabine. Side Effects for Women?

Women Side EffectsReports

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Cytarabine. reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Cytarabine. Side Effects

    Did You Have a Cytarabine. Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Cytarabine. for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Cytarabine. Safety Alerts, Active Ingredients, Usage Information

    More About Cytarabine.

    Side Effects reported to FDA: 2

    Cytarabine. safety alerts: No

    Reported hospitalizations: 2

    Latest Cytarabine. clinical trials

    Cytarabine. Reviews

    No reviews, be a first to report a side effect via side effect reporting form